Journal article
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis
Abstract
BackgroundTreatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved progression-free survival (PFS). We aimed to determine the relative effectiveness of new therapies in this field.MethodsWe conducted comprehensive searches of 11 electronic databases from inception to April 2008. We included randomized trials (RCTs) that evaluated …
Authors
Mills EJ; Rachlis B; O'Regan C; Thabane L; Perri D
Journal
BMC Cancer, Vol. 9, No. 1,
Publisher
Springer Nature
Publication Date
12 2009
DOI
10.1186/1471-2407-9-34
ISSN
1471-2407
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBenzenesulfonatesBevacizumabCarcinoma, Renal CellDisease-Free SurvivalHumansIndolesInterferon-alphaKidney NeoplasmsNiacinamidePhenylurea CompoundsPyridinesPyrrolesRandomized Controlled Trials as TopicSirolimusSorafenibSunitinib